Amylyx Pharmaceuticals, Inc. (AMLX)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqGSUnited StatesUS03237H1014
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Amylyx Pharmaceuticals, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 21:12. Information, not advice. Showing the last 90 days. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Mar 2027 08:00 | -0.37 | — | — | Upcoming |
| 05 Nov 2026 07:00 | -0.37 | -0.38 | -2.2% | Miss |
| 06 Aug 2026 07:00 | -0.36 | -0.39 | -9.0% | Miss |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Older results and the annual figures: create a free account to see them
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 28.84 | 31.88 | 27.48 | 30.29 | +4.95% | 15,800,831 | |
| Oct 2026 | 28.62 | 30.00 | 26.04 | 28.86 | -0.82% | 28,542,400 | |
| Sep 2026 | 33.49 | 35.47 | 28.64 | 29.10 | -13.78% | 31,339,100 | |
| Aug 2026 | 20.29 | 41.14 | 19.30 | 33.75 | +66.17% | 80,593,800 | |
| Jul 2026 | 17.84 | 20.94 | 16.52 | 20.31 | +13.08% | 37,324,400 | |
| 54 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Mizuho Maintains Outperform on Amylyx Pharmaceuticals, Raises Price Target to $39 (opens in a new tab) Benzinga · 10 Nov 2026 13:36
- Why Amylyx Pharmaceuticals Stock Is Up 6.8% And What's Next (opens in a new tab) Simply Wall St. · 08 Nov 2026 04:27
- Amylyx Pharmaceuticals (AMLX) Stock Looks Pricey After Positive Phase 3 Results (opens in a new tab) Simply Wall St. · 07 Nov 2026 23:12
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 29.86 USD
- Market cap
- 3.7B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow AMLX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.